Avantor, Inc. (NYSE:AVTR) Shares Purchased by Amalgamated Bank

Amalgamated Bank boosted its stake in Avantor, Inc. (NYSE:AVTR) by 0.3% in the 4th quarter, Holdings Channel reports. The firm owned 325,096 shares of the company’s stock after purchasing an additional 1,126 shares during the period. Amalgamated Bank’s holdings in Avantor were worth $6,850,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its stake in Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after purchasing an additional 625 shares during the period. Nisa Investment Advisors LLC increased its stake in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after buying an additional 835 shares during the period. Global Retirement Partners LLC lifted its holdings in Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after buying an additional 1,067 shares in the last quarter. UMB Bank n.a. boosted its position in Avantor by 56.3% in the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares during the period. Finally, CKW Financial Group grew its stake in shares of Avantor by 116.7% in the fourth quarter. CKW Financial Group now owns 5,200 shares of the company’s stock worth $110,000 after acquiring an additional 2,800 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Price Performance

Shares of AVTR opened at $17.22 on Thursday. The firm has a fifty day moving average price of $20.69 and a 200 day moving average price of $22.79. The stock has a market cap of $11.73 billion, a PE ratio of 16.56, a price-to-earnings-growth ratio of 1.55 and a beta of 1.28. Avantor, Inc. has a 1-year low of $17.14 and a 1-year high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the previous year, the firm posted $0.22 earnings per share. As a group, sell-side analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on AVTR. Royal Bank of Canada decreased their target price on Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a report on Monday, February 10th. Wells Fargo & Company lowered their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Monday, February 10th. Stifel Nicolaus lowered their price target on shares of Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a report on Monday, February 10th. UBS Group restated a “neutral” rating and issued a $25.00 price objective (down from $29.00) on shares of Avantor in a report on Friday, January 17th. Finally, Barclays decreased their price objective on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research report on Monday, February 10th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $25.92.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.